Transcatheter aortic valve implantation (TAVI) is a breakthrough technology to replace the aortic valve in patients with severe aortic stenosis using simple cardiac catheterization instead of thoracic surgery. Initiated 20 years ago by my colleagues and me, TAVI has been performed in >1.5 million patients globally and has profoundly altered the landscape of cardiovascular medicine.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lababidi, Z., Wu, J. R. & Walls, J. T. Percutaneous balloon aortic valvuloplasty: results in 23 patients. Am. J. Cardiol. 53, 194–197 (1984).
Cribier, A. et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1, 63–67 (1986).
Eltchaninoff, H. et al. Five month study of percutaneous heart valves in the systemic circulation of sheep using a novel model of aortic insufficiency. EuroIntervention 1, 438–444 (2006).
Cribier, A. et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106, 3006–3008 (2002).
Cribier, A. et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J. Am. Coll. Cardiol. 47, 1214–1223 (2006).
Webb, J. G. et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113, 842–850 (2006).
Walther, T. et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur. J. Cardiothorac. Surg. 33, 983–988 (2008).
Grube, E. et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol. 50, 69–76 (2007).
Vahanian, A. et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 43, 561–632 (2022).
Durand, E. et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc. Interv. 5, 461–467 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.C. is a consultant for Edwards Lifesciences.
Rights and permissions
About this article
Cite this article
Cribier, A. Invention and uptake of TAVI over the first 20 years. Nat Rev Cardiol 19, 427–428 (2022). https://doi.org/10.1038/s41569-022-00721-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-022-00721-w
